| PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition YH Ibrahim, C García-García, V Serra, L He, K Torres-Lockhart, A Prat, ... Cancer discovery 2 (11), 1036-1047, 2012 | 592 | 2012 |
| TAK1 activates AMPK‐dependent cytoprotective autophagy in TRAIL‐treated epithelial cells G Herrero‐Martín, M Høyer‐Hansen, C García‐García, C Fumarola, ... The EMBO journal 28 (6), 677-685, 2009 | 467 | 2009 |
| Dual mTORC1/2 and HER2 blockade results in antitumor activity in preclinical models of breast cancer resistant to anti-HER2 therapy C García-García, YH Ibrahim, V Serra, MT Calvo, M Guzmán, J Grueso, ... Clinical cancer research 18 (9), 2603-2612, 2012 | 174 | 2012 |
| RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer V Serra, PJA Eichhorn, C García-García, YH Ibrahim, L Prudkin, ... The Journal of clinical investigation 123 (6), 2551-2563, 2013 | 146 | 2013 |
| PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition. Cancer Discov. 2012; 2: 1036–1047. doi: 10.1158/2159 … YH Ibrahim, C García-García, V Serra, L He, K Torres-Lockhart, A Prat, ... vitro/in vivo, 2013 | 101 | 2013 |
| Deletion of the Snord116/SNORD116 Alters Sleep in Mice and Patients with Prader-Willi Syndrome G Lassi, L Priano, S Maggi, C Garcia-Garcia, E Balzani, N El-Assawy, ... Sleep 39 (3), 637-644, 2016 | 71 | 2016 |
| AMPK-independent down-regulation of cFLIP and sensitization to TRAIL-induced apoptosis by AMPK activators C García-García, C Fumarola, N Navaratnam, D Carling, A López-Rivas Biochemical pharmacology 79 (6), 853-863, 2010 | 30 | 2010 |
| Parent-of-origin genetic background affects the transcriptional levels of circadian and neuronal plasticity genes following sleep loss F Tinarelli, C Garcia-Garcia, F Nicassio, V Tucci Philosophical Transactions of the Royal Society B: Biological Sciences 369 …, 2014 | 25 | 2014 |
| Working-for-food behaviors: a preclinical study in Prader-Willi mutant mice G Lassi, S Maggi, E Balzani, I Cosentini, C Garcia-Garcia, V Tucci Genetics 204 (3), 1129-1138, 2016 | 21 | 2016 |
| MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer C García-García, MA Rivas, YH Ibrahim, MT Calvo, A Gris-Oliver, ... Clinical Cancer Research 21 (24), 5499-5510, 2015 | 19 | 2015 |
| PI3K activation promotes resistance to eribulin in HER2-negative breast cancer A Gris-Oliver, YH Ibrahim, MA Rivas, C García-García, M Sánchez-Guixé, ... British Journal of Cancer 124 (9), 1581-1591, 2021 | 13 | 2021 |
| A novel unsupervised analysis of electrophysiological signals reveals new sleep substages in mice VM Katsageorgiou, D Sona, M Zanotto, G Lassi, C Garcia-Garcia, V Tucci, ... PLoS biology 16 (5), e2003663, 2018 | 13 | 2018 |
| The after-hours circadian mutant has reduced phenotypic plasticity in behaviors at multiple timescales and in sleep homeostasis S Maggi, E Balzani, G Lassi, C Garcia-Garcia, A Plano, S Espinoza, L Mus, ... ScIENTIfIc RePoRTS 7 (1), 17765, 2017 | 8 | 2017 |
| Fumarola c, Farkas T, López-Rivas A@ and Jäättelä M@(2009) TAK1 activates AMPK and AMPK-dependent cytoprotective autophagy in TRAIL-treated breast epithelial cells G Herrero-Martin, M Høyer-Hansen, C García-García EMBO Journal 28, 677-685, 0 | 5 | |
| Role of GNAS imprinted gene in neurodevelopment, sleep and cognition C Garcia-Garcia, E Balzani, C Chiabrera, L Cancedda, V Tucci JOURNAL OF SLEEP RESEARCH 25, 97-97, 2016 | | 2016 |
| MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer (vol 21, pg 5499, 2015) C Garcia-Garcia, MA Rivas, YH Ibrahim, MT Calvo, A Gris-Oliver, ... CLINICAL CANCER RESEARCH 22 (15), 3982-3982, 2016 | | 2016 |
| Role of GNAS imprinted gene in neurodevelopment, sleep and cognition C Garcia-Garcia, L Cancedda, V Tucci JOURNAL OF NEUROCHEMISTRY 134, 112-112, 2015 | | 2015 |
| Abstract B38: p90RSK mediates resistance to PI3K-pathway inhibitors in breast cancer PJA Eichhorn, V Serra, C Garcia-Garcia, YH Ibrahim, L Prudkin, JL Parra, ... Molecular Cancer Therapeutics 14 (7_Supplement), B38-B38, 2015 | | 2015 |
| Erratum: RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer (Journal of Clinical Investigation (2013) 123: 6 (2551-2563 V Serra, P Eichhorn, C García-García, Y Ibrahim, L Prudkin, G Sánchez, ... Journal of Clinical Investigation 124 (3), 2014 | | 2014 |
| PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes YH Ibrahim, C García-García, V Serra | | 2012 |
Violeta Serra, PhDPrincipal InvestigatorVerified email at vhio.net
